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Abstract: Systemic lupus erythematosus frequently involves the kidneys leading to significant morbidity and 
mortality. It is classified according to glomerular involvement pattern but tubulointerstitial lesions are also im-
portant for progression and prognosis, as seen in other kidney glomerular diseases. One of the cell types which 
participate in this process are mast cells. The aim of the study was to analyze the counts of tryptase-positive 
and chymase-positive mast cells in lupus nephritis classes II, III and IV. Material consisted of 42 renal biopsies 
from patients with lupus nephritis; 11 class II, 9 class III and 22 class IV. Chymase- and tryptase-containing 
cells were stained by immunohistochemistry and counted microscopically. Mean count of chymase-positive mast 
cells was 9.8/10 high power fields (hpf) for the whole group, 4.66 for class II, 11.89 for class III, and 11.51 for 
class IV. The mean count of tryptase-positive cells was 18.6/10 hpf for the whole group, 7.65 for class II, 25.57 
for class III, and 21.23 for class IV. The differences between lupus nephritis classes were significant both for 
chymase- and tryptase-positive cells. Tryptase- but not chymase-positive cell counts showed a correlation with 
the creatinine level (R = 0.35). These results suggest that mast cells are involved to a different degree in the 
pathogenesis of lupus nephritis depending on the class of the disease. (Folia Histochemica et Cytobiologica 2014, 
Vol. 52, No. 3, 218–224)
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Introduction
Systemic lupus erythematosus (SLE) is an autoimmu-
ne disease involving several organs and systems, most 
prevalent in young to middle-aged women. Its preva-
lence worldwide varies from 40/100,000 in Northern 
Europeans to 100/100,000 in Africans and 150/100,000 
in Brazilians; exact epidemiologic data from Poland 
is lacking, however, the frequency of SLE appears to 
be increasing [1–3]. 5-year and 10-year mortality in 
long-term studies is about 10% and 30% respectively, 
with the main causes of death being infections, car-
diovascular disease and direct organ damage [2–4]. 
Involvement of the kidney is frequent; lesions of 
particular importance are glomerulonephritis and the 
resulting tubulointerstitial changes. For prognostic 
and therapeutic purposes, glomerular lesions in SLE 
are classified by the International Society of Nephro-
logy/Renal Pathology Society (ISN/RPS) system or the 
older World Health Organization (WHO) system [5]. 
It is important to note that renal involvement is the 
most frequent SLE organ damage-related cause of 
death [4].
Lupus nephritis (LN) results from the activity of 
multiple biologic factors like autoantibodies, inflam-
matory cells, growth factors, chemokines, cytokines, 
reactive oxygen and nitrogen species. Similarly to 
other forms of glomerulonephritis, glomerular in-
flammation leads to tubular epithelial cell activation, 
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interstitial inflammation and interstitial fibrosis, 
which is ultimately responsible for renal failure [6–8]. 
One of the cell types present in chronically inflamed 
renal interstitium is the mast cell (MC). It has been 
shown that mast cells actively participate in interstitial 
inflammation and contribute to renal fibrosis [8–10].
Human mast cells are characterized by the presen-
ce of granules which contain two proteases: tryptase 
and chymase. Since only a proportion of mast cells 
is positive for chymase, two classes of mast cells, 
chymase-positive and chymase-negative, may be di-
stinguished [11]. In cases of inflammation or injury, 
chymase is released into the interstitium and by acti-
vating latent transforming growth factor-b (TGF-b), is 
implicated in tissue remodeling. The number of mast 
cells correlates with the severity of tubulointerstitial 
disease: chymase-positive mast cells correlate with the 
severity of interstitial fibrosis and intra-renal vascular 
resistance [9]. Mast cell tryptase may also be involved 
in the development of interstitial fibrosis [10].
The aim of the study was to analyze the counts of 
tryptase-positive and chymase-positive mast cells in 
lupus nephritis and compare these counts between 
ISN/RPS classes II, III and IV. We analyzed tubuloin-
terstitial infiltration of chymase- and tryptase-positive 
mast cells in patients with lupus nephritis class II, III 
and IV and examined the relationship between lupus 
classification, cell infiltration and renal function.
Material and methods
Patients. The material consisted of representative renal 
biopsies from 42 patients with lupus nephritis (35 females 
and 7 males) retrieved from the archives of the Department 
of Pathomorphology (Collegium Medicum, Jagiellonian 
University, Cracow). Eleven patients were classified as 
lupus nephritis class II (Figure 1), 9 patients as class III, 
22 patients as class IV (Figure 2).
Histology and histomorphology. The material was fixed in 
formalin, processed by routine method and embedded in 
paraffin. From the paraffin blocks, 4 μm sections were cut 
and stained. For histologic classification, sections were sta-
ined by standard hematoxylin and eosin, periodic acid–Shiff, 
Massons’ trichrome, Congo red, and Jones’ silver methods. 
Only representative biopsies were used for this study. The 
cases were classified according to ISN/RPS criteria, and 
the activity and chronicity indexes as included in ISN/RPS 
system were calculated [5]. For the present study, only ca-
ses belonging to class II, III and IV were chosen; the more 
detailed sub-classification was disregarded for the purpose 
of statistical analysis.
Primary anti-tryptase antibody (1:100; Leica Biosystems 
GmbH, Wetzlar, Germany) and anti-chymase antibody 
(1:100; Abcam, Cambridge, UK) were used. The immuno-
histochemistry was done by routine manual method. The 
Lab Vision detection system (Thermo Fisher Scientific, 
Waltham, MA, USA) was used. 3-amino-9-ethylcarbasole 
Figure 1. Glomerulus with only mild mesangial prolifera-
tion, consistent with lupus nephritis class II. Hematoxylin 
and eosin (H & E) staining, original magnification × 400
Figure 2. Extensive mesangial proliferation with increased 
lobulation may represent class III or class IV lesions,  
depending on the number of glomeruli involved (< 50%  
v. > 50%). H & E staining, original magnification × 400
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was used as the chromogen. The slides were counterstained 
with Mayer hematoxylin (Thermo Fisher Scientific) and 
coverslipped. The immunostained slides (Figures 3 and 4) 
were examined on Olympus CH20 microscope (Olympus, 
Tokyo, Japan) equipped with a 40× lens; the number of 
immunopositive cells, as well as number of fields of view 
were documented. The results were expressed as a sum 
of positive cells from 10 high power fields (hpf), while the 
area of one hpf was 0.159 mm2. The person performing the 
assessment was not aware of the diagnoses or clinical data. 
The values of serum creatinine and daily proteinuria were 
obtained from the patients’ records.
For the assessment of relative interstitial volume (RIV), 
Massons’ trichrome stained sections were used with a Zeiss 
Standard 25 (Zeiss GmbH, Oberkochen, Germany) mi-
croscope equipped with a 121-point rectangular eyepiece 
grid (Pyser-SGI Ltd., Edenbridge, UK) and a 40× lens. 
The well-preserved area of the renal cortex was scanned, 
noting both the number of fields of view and number of 
grid cross sections hitting the renal interstitium. The vessels 
larger than arterioles and glomeruli were disregarded. The 
result was expressed as the ratio of the points sampled in 
the interstitium to the total number of points sampled in 
the renal cortex.
Statistical methods. The statistical analysis was perfor-
med with Statistica 10 (StatSoft Inc., Tulsa, OK, USA). 
Kruskal-Wallis ANOVA and Mann-Whitney U tests were 
used, when appropriate. Correlations were measured by 
Spearman’s correlation coefficient. The significance level 
was set at 0.05.
Results
Clinical characteristics of patients
Mean age of all patients was 33.9 ± 9.5 years (all 
values expressed as arithmetic mean ± SD), range 
19–56 years. For class II the mean age was 38.5 
± 14.3, in class III — 36.0 ± 10.0, and in class IV it 
was 31.9 ± 8.3 years. Mean age was 34.2 ± 10.5 years 
for females and 33.3 ± 11.7 years for males. The dif-
ferences between patient’s mean age in the classes or 
gender were statistically non-significant.
Activity index determined according to ISN/RPS 
criteria [5] ranged from 1 to 14 (median 4), as expec-
ted, shown significant differences between the main 
ISN/RPS classes (median 1 for class II, 4 for class III 
and 7 for class IV, p < 0.001). Chronicity index score 
determined according to ISN/RPS criteria [5] ranged 
from 0 to 8 (median 2), presented only slight and 
non-significant differences between ISN/RPS classes 
(median 1 for class II, 3 for class III and 2 for class IV). 
Mean creatinine serum concentration was 85.3 
± 38.1 μmol/l, range 40 to 192 μmol/l. In lupus 
nephritis class II mean creatinine level was 74.6 
± 24.1 μmol/l, in class III — 86.5 ± 34.2 μmol/l, 
and in class IV — 90.3 ± 43.9 μmol/l. Mean daily 
proteinuria level was 3.5 ± 3.0 g/d, range 0 to 11 g/d. 
In lupus nephritis class II mean daily proteinuria was 
2.73 ± 3.0 g/d, in class III — 2.62 ± 1.4 g/d, and in 
class IV — 4.31 ± 3.5 g/d. The differences between the 
lupus nephritis classes were statistically non-signi-
ficant.
Figure 3. Chymase-positive cells in renal interstitium. Im-
munohistochemical staining was performed as described in 
Methods, original magnification × 400
Figure 4. Tryptase-positive cells in renal interstitium. Im-
munohistochemistry, original magnification × 400
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Histomorphometric evaluation of mast cells  
in the renal interstitium of lupus nephritis patients
In all lupus nephritis patients the mean relative 
interstitial volume (RIV) was 0.18 ± 0.09, range 
0.06 to 0.4. In class II of lupus nephritis mean RIV 
was 0.14, in class III — 0.19, and in class IV — 0.20 
(the differences between groups were non-signi-
ficant).
The mean count of chymase-positive mast cells 
(MCs) was 9.8 ± 8.6 per 10 high power fields, while 
the mean count for tryptase-positive MCs was 18.6 
± 18.4. The average ratio of chymase-positive to 
tryptase-positive cells count was 0.77 ± 0.71.
Table 1 presents the values for each lupus nephri-
tis class. The differences between chymase-positive 
and tryptase-positive cells counts were statistically 
significant (p < 0.035 and p < 0.016, respectively; 
Figures 5 and 6). On post-hoc analysis the differences 
in chymase-positive MCs were found between class II 
and IV, whereas the number of tryptase-positive MCs 
differed between class II and III and class II and IV. 
The differences in the ratio of chymase-positive 
to tryptase-positive cells between lupus nephritis 
classes were not significant; however, there was 
a significant inverse correlation between the ratio of 
chymase-positive to tryptase-positive cells and pa-
tients’ age (R = –0.36; p < 0.025). Chymase-positive 
MC counts and tryptase-positive MC counts were 
strongly correlated (R = 0.67). Both chymase- and 
tryptase-positive MC counts correlated with disease 
activity index (R = 0.31 and R = 0.46, respectively) 
and a chronicity index (R = 0.36 and R = 0.48, re-
spectively). Both chymase-positive MC counts and 
tryptase-positive MC counts correlated with RIV 
(R = 0.35 and R = 0.40, respectively). The trypta-
se-positive MC count showed a positive correlation 
with creatinine level (R = 0.33) and proteinuria 
(R = 0.31). The chymase-positive MC count showed 
a weak correlation with proteinuria level (R = 0.20) 
and RIV showed a weak correlation with creatinine 
serum concentration (R = 0.25) and patients’ age 
(R = 0.18). The disease activity index correlated with 
proteinuria (R = 0.41). 




Tryptase-positive Chymase-positive Chymase-/tryptase-positive ratio
Mean SD Min Max Mean SD Min Max Mean SD Min Max
II (11) 7.65 6.19 1 18 4.66 4.10 1 13 0.94 1.06 0.20 3.33
III (9) 25.57* 21.17 4 68 11.89 11.22 1 33 0.49 0.37 0.13 1.42
IV (22) 21.23* 19.46 2 79 11.51** 8.33 3 30 0.80 0.59 0.05 2.50
Number of patients is given in parenthesis. Mast cell counts were measured as described in Methods. SD — standard deviation; *, **significantly 
different from class II, p < 0.05 and p = 0.01, respectively; Kruskal-Wallis ANOVA
Figure 5. Number of chymase-positive cells by lupus ne-
phritis ISN/RPS classes (II–IV). Y axis: number of cells  
per 10 high power fields
Figure 6. Number of tryptase-positive cells per high power 
field by lupus nephritis ISN/RPS classes (II–IV). Y axis: 
number of cells per 10 high power fields
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As indicated above, lupus nephritis is an important 
cause of morbidity and mortality in patients with 
SLE [4]. The exact pathogenesis of lupus as well as 
lupus nephritis is yet to be definitely determined. 
The main mechanism responsible for organ injury, 
including kidney disease, is immune complex depo-
sition. These immune complexes, which may consist of 
antinuclear antibodies and nuclear material, deposit 
in the tissues activating complement and interac-
ting with complement receptors. Impaired immune 
complex clearing is thought to be one of the major 
pathogenetic mechanisms in SLE. In the kidney, the 
immune complexes are deposited primarily under the 
endothelium and in mesangium, leading to activa-
tion of mesangial cells and podocytes, which secrete 
a number of inflammatory mediators. This results in 
interstitial inflammation and, finally, renal interstitial 
fibrosis. Tubulointerstitial damage plays a key role in 
glomerulonephritis, including lupus nephritis; in most 
cases the decrease in glomerular filtration rate corre-
lates more with interstitial kidney damage than with 
glomerular fibrosis [2]. Some authors have suggested 
that various forms of lupus nephritis may differ in 
their immunopathogenesis; only global forms would 
be related to classic immune complex deposition [12]. 
Renal interstitial infiltrates in SLE are very common, 
especially in more active (class III and IV) forms of the 
disease. These infiltrates are composed of a heteroge-
neous population of cells interacting with each other. 
Specifically T cells, B cells, macrophages and dendritic 
cells (DCs) play an important role in the develop-
ment of lupus nephritis and kidney damage [13, 14] 
with each cell type possessing distinctive functions. 
Periglomerular inflammation caused by glomerular 
antigen-reactive T cells in the renal cortex leads to 
increased macrophage infiltration. Macrophages are 
most likely attracted to the renal interstitium by T cell
-derived signals [14]. B cells produce autoantibodies 
responsible for the tissue damage and may play a role 
as potential antigen presenting cells and regulators 
for the purpose of T cell [15], macrophage and DCs 
migration and activation [16]. Dendritic cells produce 
several pro-inflammatory and pro-fibrotic factors [17]. 
They enhance the presentation of auto-antigens and 
the induction of autoimmunity [18]. Additionally, they 
promote the expansion of T and B cells which leads 
to tissue damage [19].
Mast cells are also present in the inflammatory 
infiltrate, though in far lower number. Usually they 
may be visualized only by immunohistochemistry, 
thus their role in the pathogenesis of lupus nephritis 
was neglected. They show proinflammatory actions, 
secreting a great number of factors and taking part 
in many processes such as angiogenesis, bone remo-
deling, atherosclerosis, reactions to neoplasms and 
wound healing [20]. They are involved in chronic 
inflammation and renal fibrosis similar to tubuloin-
terstitial damage which occurs during glomerulone-
phritis. Mast cells are rarely seen in healthy kidney, 
but their number increases in the kidney interstitium 
during disease; this can be seen in diabetic nephropa-
thy, acute renal allografts rejection, IgA nephropathy, 
amyloidosis, renovascular ischemia, reflux nephro-
pathy, polycystic kidney disease and drug-induced 
nephropathy [11, 21–24]. They were found in renal 
cortical tubulointerstitium, the periglomerular and 
perivascular areas, but not in glomeruli [8, 11, 21]. 
The number or mast cells parallels the tubulointer-
stitial injury and decline of renal function, measured 
by serum creatinine concentration [21].
There are some studies concerning quantification 
of mast cells in lupus nephritis, yet, little is known 
about the relative importance of mast cell popula-
tions, as well as their role in specific types of nephritis. 
Hiromura et al. analyzed both primary glomerulone-
phritis and kidney involvement in systemic processes 
including lupus [21]. They showed a significant cor-
relation between the number of mast cells and the 
serum creatinine concentration at the time of biopsy 
but found no correlation between the number of mast 
cells and daily urinary protein excretion; this was true 
for all but crescentic glomerulonephritis. Similarly, 
in the present study the overall number of mast cells 
correlated with creatinine level. Unlike Hiromura et 
al., we found a significant correlation between the 
number of mast cells and proteinuria. The differences 
between studies may be due to different selection of 
cases, as we limited our material to class II, III and 
IV. Unfortunately, Hiromura et al. failed to report 
the details of lupus nephritis group [21]. Ravinal et 
al. [25] showed a correlation of tryptase-positive mast 
cells with tubulointerstitial a-smooth muscle actin 
expression in class V lupus nephritis, but not in the 
other classes. Furthermore, no correlations between 
the number of MCs and lupus outcome or interstitial 
TGF-b1 expression were observed [25]. Danilewicz 
et al. analyzed similar material, and showed that 
the number of interstitial tryptase-positive cells was 
significantly increased in class V lupus nephritis as 
compared to idiopathic membranous glomerulopa-
thy [26]. In both idiopathic and lupus-related disease, 
there were significant positive correlations between 
interstitial tryptase-positive MCs number and inter-
stitial expansion, as well as serum creatinine level, 
which suggests possible relationship between mast 
cells and the development of interstitial fibrosis [26]. 
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Our and other authors’ results [25, 26] suggest 
that mast cells contribute to renal damage in different 
lupus nephritis classes. In our study, we were able to 
show significant differences between the individual 
classes of lupus nephritis which represents a novel 
finding, as yet not described in the literature.
The role of mast cells in other kinds of renal dise-
ase has been better appreciated. Danilewicz et al. [27] 
found a significant increase of mast cells in mesan-
giocapillary glomerulonephritis. In their material, 
MC count correlated with the degree of interstitial 
fibrosis, macrophage count, interstitial myofibroblasts 
and renal function parameters [27]. In an another 
study [28] the same group analyzed paired biopsies 
of patients with idiopathic mesangioproliferative 
glomerulonephritis. They found a significant incre-
ase in mast cell counts along with interstitial fibrosis, 
macrophage count and interstitial myofibroblasts, but 
not in T or B lymphocytes’ number. Surprisingly, this 
interstitial remodeling was accompanied by reduction 
of proteinuria. Okon et al. [11] analyzed both pri-
mary glomerulonephritis and diabetic nephropathy 
and found a significant correlation between mast 
cell count, interstitial fibrosis and renal functional 
parameters. Highest MC counts were present in dia-
betic nephropathy, but an increase was also present 
in primary glomerulonephritis. Unlike in the present 
study, chymase-positive cells number showed stronger 
correlation with renal function than tryptase-positive 
cells [11]. Papadimitriou et al. analyzed the role of 
mast cells on renal allografts, and noticed a signifi-
cant correlation between mast cell number and the 
degree of interstitial fibrosis but not with the activity 
of neither cellular nor humoral rejection [29]. On the 
other hand, some studies suggest that mast cells may 
act as a protective factor in renal disease. It has been 
hypothesized that one of the protective factors could 
be mast cell chymase [30]. Even better established is 
the role of chymase as an alternative angiotensin con-
vertase; locally generated angiotensin may increase 
proteinuria as well as systemic blood pressure [31]. 
Our results suggest that chymase is generated in lupus 
nephritis, yet its influence on renal function is weaker 
than in other renal disease, such as diabetic nephro-
pathy [11]. Interestingly, we found that the proportion 
of mast cells expressing chymase decreases with age; 
this feature was not observed in other diseases and 
by other studies. 
In conclusion, for the first time we have shown 
that mast cell counts differ between classes of lupus 
nephritis. This could suggest that the role of these cells 
may differ across different classes of lupus nephritis. 
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